| Literature DB >> 29191075 |
Assia Khalfallah1, Djemaa Berrehal1, Chawki Bensouici2, Ahmed Kabouche1, Zahia Semra1,3, Laurence Voutquenne-Nazabadioko4, Abdulmagid Alabdul Magid4, Zahia Kabouche1.
Abstract
CONTEXT: Phytochemical study and biological potential of Evax pygmaea (L.) Brot. (Asteraceae) are reported for the first time.Entities:
Keywords: ABTS; CUPRAC; DPPH; MIC; metal chelating; β-carotene/linoleic acid
Mesh:
Substances:
Year: 2017 PMID: 29191075 PMCID: PMC6130525 DOI: 10.1080/13880209.2017.1405997
Source DB: PubMed Journal: Pharm Biol ISSN: 1388-0209 Impact factor: 3.503
Figure 1.Structures of compounds (1–6) isolated from Evax pygmaea.
Total polyphenolic content of ethyl acetate (EAEP) and n-butanol (BEP) fractions of Evax pygmaea.
| Plant fractions | Total phenolic content (mg/g) |
|---|---|
| EAEP | 349.69 ± 2.20 |
| BEP | 273.31 ± 2.60 |
Values are mean ± SD (n = 3).
mg/g gallic acid equivalent.
Antioxidant activity of E. pygmaea fractions by the DPPH, ABTS, CUPRAC, metal chelating and β-carotene assays.
| Antioxidant activity | |||||
|---|---|---|---|---|---|
| DPPH assay | ABTS assay | β-Carotene assay | CUPRAC assay | Metal chelating assay | |
| Extracts | IC50 (µg/mL) | % Inhibition at 100 µg/mL | |||
| CEP | 49.21 ± 0.26 | 10.61 ± 0.38 | 9.01 ± 1.19 | 31.16 ± 1.02 | >50 |
| EAEP | 6.91 ± 0.09 | <3.125 | 4.07 ± 1.12 | 6.26 ± 0.04 | 3.74 ± 0.61 |
| BEP | 10.47 ± 0.18 | 8.88 ± 0.19 | <3.125 | 11.66 ± 0.76 | 13.95 ± 1.00 |
| BHA | 5.73 ± 0.41 | 1.81 ± 0.10 | 0.90 ± 0.02 | 3.64 ± 0.19 | 8.41 ± 0.67 |
| BHT | 22.32 ± 1.19 | 1.29 ± 0.30 | 1.05 ± 0.01 | 9.62 ± 0.87 | >50 |
| Ascorbic acid | – | – | – | – | 9.01 ± 1.46 |
IC50 and A0.50 values expressed are means ± SD of three parallel measurements (p < 0.05).
Reference compounds: BHA: butylated hydroxyanisole; BHT: butylated hydroxytoluene.
Antibacterial activity (MICs) of the chloroform (CEP), ethyl acetate (EAEP) and n-butanol (BEP) fractions of Evax pygmaea.
| Bacteria | MIC | |||
|---|---|---|---|---|
| CEP | EAEP | BEP | Genta | |
| 80 ± 0.50 | 40 ± 0.20 | 40 ± 0.70 | 10 ± 0.20 | |
| 80 ± 1.20 | 40 ± 1.00 | 40 ± 2.30 | 15 ± 0.30 | |
| 80 ± 1.50 | 40 ± 0.80 | 40 ± 1.90 | 5 ± 0.10 | |
| 40 ± 0.50 | 80 ± 0.20 | – | 5 ± 0.20 | |
| 80 ± 2.50 | 80 ± 0.80 | 80 ± 1.70 | – | |
| 80 ± 0.35 | – | – | – | |
| 80 ± 1.90 | 80 ± 1.40 | 80 ± 0.70 | – | |
Values are mean ± SD (n = 3).
Gentamycin: 10 µg/mL.
Obtained from the Pasteur Institute (Algiers).
Clinical isolates from the laboratory of bacteriology (CHU Constantine, Algeria).
Cytotoxic activity of extracts of E. pygmaea.
| % Mortality rate | ||||||
|---|---|---|---|---|---|---|
| Plant fractions | 10 µg | 20 µg | 40 µg | 80 µg | LD50 | Toxicity |
| EAEP | 0.00 ± 0.00 | 0.00 ± 0.00 | 0.00 ± 0.00 | 3.33 ± 1.77 | >80 | – |
| BEP | 0.00 ± 0.00 | 0.00 ± 0.00 | 6.67 ± 1.55 | 13.33 ± 1.77 | >80 | – |
| CEP | 3.33 ± 1.77 | 6.67 ± 1.55 | 13.33 ± 5.77 | 20.00 ± 00.00 | >80 | – |
Values expressed are means ± SD of three parallel measurements (p< 0.05).
LD50: median lethal dose.